EuroIntervention/X
Jun 30, 2025, 15:19
Study Explored the Use of Paclitaxel-Coated Balloons for Stabilizing Vulnerable Lipid-Rich Plaques in ACS Patients – EuroIntervention
EuroIntervention shared on X:
“This study explored the use of paclitaxel-coated balloons for stabilizing vulnerable lipid-rich plaques in ACS patients. Discover how this approach could reduce future coronary events.”
Title: Paclitaxel-coated balloons for vulnerable lipid-rich plaques.
Authors: Anna van Veelen, I. Tarik Küçük, Hector M. García-García, Federico H. Fuentes, Yirga Kahsay, Ronak Delewi, Marcel A.M. Beijk, Alexander W. den Hartog, Maik J. Grundeken, M. Marije Vis, José P.S. Henriques, Bimmer E.P.M. Claessen.

Read the full research.
You can find more posts on Hemostasis Today.
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target
-
Oct 7, 2026, 15:28Amir Samimi: Prognostic Value of Platelet Count in Resected HNSCC
-
Oct 7, 2026, 15:21Eloïse Laouenan: Bridging Immunity and Thrombosis in MVTE
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story
-
Oct 7, 2026, 14:49Aimee Burtenshaw: The Impact of the Infected Blood Inquiry on Hospital Transfusion Laboratories
-
Oct 7, 2026, 14:41Vikash Jaiswal: Does Timing Matter for Calcium in Pre-Eclampsia Prevention?